Urokinase (PLAU) Antibody Blocking peptide
Urokinase (PLAU) Antibody Blocking peptide
Product Specifications
Product Name Alternative
Urokinase-type plasminogen activator, U-plasminogen activator, uPA, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A, Urokinase-type plasminogen activator chain B, PLAU
UniProt
P00749
Field of Research
Cardiovascular Research
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1928539 was selected from the C-term region of human PLAU . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM1863-50 1x 50 µL
Chromogranin A / CHGA (Neuroendocrine Marker) (rCHGA/777), 1mg/mL
Sign In for Pricing
View Details 
BNC042595-500 1x 500 µL
PAX5 / BSAP (Early B-Cell Marker) (PAX5/2595), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB2879-100 1x 100 µL
Drebrin 1 (DBN1) (DBN1/2879), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472882-500 1x 500 µL
Cystatin A (CSTA/2882), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details